Evaluation of the relationship between glycated hemoglobin A1c and mean glucose levels derived from the professional continuous flash glucose monitoring system
“…However, our data showed a weakening of the relationship between HbA1c and a range of glucose parameters on SUEDs versus non‐SUEDs. In most studies from the literature, a linear relationship exists between HbA1c and glycaemic control parameters such as mean SG and time out of range 24,25 . We found that HbA1c was less closely associated with mean SG, time out of range (SG < 3.9 and >10 mmol/L) and time with SG > 10 mmol/L on days when substances were used.…”
Section: Discussionmentioning
confidence: 64%
“…In most studies from the literature, a linear relationship exists between HbA1c and glycaemic control parameters such as mean SG and time out of range. 24,25 We found that HbA1c was less closely associated with mean SG, time out of range (SG < 3.9 and >10 mmol/L) and time with SG > 10 mmol/L on days when substances were used. Also, a dose-dependent effect was observed for those days when alcohol alone was consumed.…”
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
“…However, our data showed a weakening of the relationship between HbA1c and a range of glucose parameters on SUEDs versus non‐SUEDs. In most studies from the literature, a linear relationship exists between HbA1c and glycaemic control parameters such as mean SG and time out of range 24,25 . We found that HbA1c was less closely associated with mean SG, time out of range (SG < 3.9 and >10 mmol/L) and time with SG > 10 mmol/L on days when substances were used.…”
Section: Discussionmentioning
confidence: 64%
“…In most studies from the literature, a linear relationship exists between HbA1c and glycaemic control parameters such as mean SG and time out of range. 24,25 We found that HbA1c was less closely associated with mean SG, time out of range (SG < 3.9 and >10 mmol/L) and time with SG > 10 mmol/L on days when substances were used. Also, a dose-dependent effect was observed for those days when alcohol alone was consumed.…”
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
“…This observation emphasizes that the measurement of DM management, with respect to the glycemic control, should not be focused only on the mean of the glycemic values but also on the dispersion of those values around the average. This association is supported by several articles [42][43][44]. A recent study that included over 600 young patients with T1DM showed a positive correlation between SD and HbA1c, indicating that a higher HbA1c leads to poorer glycemic control [42].…”
Background: Glycemic variability (GV) is a novel parameter used in evaluating the quality of diabetes management. Current guidelines recommend the use of GV indexes alongside the traditional parameter to evaluate glycemic control: hemoglobin A1c (HbA1c). This study aims to evaluate the extent to which HbA1c explains the GV phenomena in patients with Type 1 diabetes (T1DM). Methods: In 147 patients with T1DM, associations between HbA1c and several GV indexes were analyzed. Results: Patients with an HbA1c < 7% had a lower median standard deviation of glycemia (60 vs. 48; p < 0.001), a lower coefficient of variation (34.1 vs. 38.0; p < 0.001), and a significantly increased median time in range (78 vs. 58; p < 0.001). HbA1c was positively correlated with the coefficient of variation (r = 0.349; p < 0.001) and the standard deviation (r = 0.656; p < 0.001) but reversely correlated with a lower time in range (r = −0.637; p < 0.001). Conclusions: HbA1c only partially explains the GV phenomena in patients with T1DM. The HbA1c value is associated more strongly with the time in range and standard deviation than with the coefficient of variation.
“…Type 2 diabetes mellitus is more common in the elderly. With the increase of the elderly population in recent years, the incidence rate of type 2 diabetes mellitus exhibits an upward trend, so it has become a public health problem endangering people's health [12] . In clinical practice, the pathogenesis of type 2 diabetes mellitus is not completely clear and there is still a lack of means to cure type 2 diabetes mellitus.…”
Liu et al.: Monitoring of Type 2 Diabetes MellitusTo explore the role of flash glucose monitoring system combined with insulin pump in the blood glucose treatment of patients with type 2 diabetes mellitus. Eighty patients with type 2 diabetes mellitus treated in our hospital from September 2019 to September 2020 were randomly divided into two groups (n=40) using a random number table. Both groups received hypoglycemic treatment using an insulin pump. During treatment, blood glucose level was measured by collecting the fingertip blood of control group, while dynamic blood glucose monitoring was carried out for observation group using the flash glucose monitoring system. Blood glucose indices, time of controlling blood glucose to target level, insulin dosage, incidence rate of hypoglycemia, comfort score; mental state scores, sleep quality score and quality of life score were compared. After treatment, fasting blood glucose and 2 h postprandial blood glucose were lower, time of controlling blood glucose to target level was shorter and insulin dosage was smaller in observation group than those in control group (p<0.05). Observation group had lower incidence rate of hypoglycemia, Self-rating Anxiety Scale, Self-rating Depression Scale and Pittsburgh Sleep Quality Index scores, as well as higher comfort and quality of life scores than those of control group (p<0.05). In the intensive hypoglycemic treatment of patients with type 2 diabetes mellitus using an insulin pump, the application of flash glucose monitoring system can effectively control blood glucose, accelerate blood glucose control and reduce insulin dosage and hypoglycemia reaction, which is helpful to raise the comfort level of patients, ameliorate the psychological and sleep states and improve the quality of life.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.